Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2010
12/02/2010WO2010136573A1 Method for the manufacture of aminopolyalkylene phosphonic acids
12/02/2010WO2010136566A1 Method for the manufacture of amino alkylene phosphonic acids
12/02/2010WO2010136565A1 Method for the manufacture of dialkylphosphites
12/02/2010WO2010136564A1 Process for the manufacture of dialkylphosphites
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010WO2010093210A3 Photoactive compound and photosensitive resin composition containing the same
12/02/2010WO2010004597A8 Process for the production of n-acyl-phosphatidyl-ethanolamine
12/02/2010US20100305361 Macromolecular antioxidants based on sterically hindered phenols and phosphites
12/02/2010US20100305336 Preparation method of copolymerizable photoinitiators
12/02/2010US20100305296 Catalyst for Producing Polyester and Method for Producing Polyester
12/02/2010US20100305252 Halogenated Phosphonates, Processes for Their Preparation and Their Use as Flame Retardants
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305069 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010US20100303804 Composition that can be cured by polymerisation for the production of biodegradable, biocompatible, cross-linkable polymers on the basis of polyvinyl alcohol
12/02/2010US20100300971 Zwitterionic stationary phase as well as method for using and producing said phase
12/02/2010CA2763761A1 Method for the manufacture of aminopolyalkylene phosphonic acids
12/02/2010CA2763610A1 Method for the manufacture of phosphonoalkyl iminodiacetic acids
12/02/2010CA2760619A1 Method for the manufacture of dialkyl phosphites
12/02/2010CA2760618A1 Method for the manufacture of amino alkylene phosphonic acids
12/02/2010CA2760604A1 Method for the manufacture of dialkylphosphites
12/02/2010CA2760603A1 Process for the manufacture of dialkylphosphites
12/01/2010EP2256124A1 Phospho-indoles as HIV inhibitors
12/01/2010EP2256122A1 Halogen-free derivatives of triazin and heptazin
12/01/2010EP2254895A1 Imidazole group-containing phosphorus compounds
12/01/2010EP1791851B1 Process for preparation of alkyl phosphinates
12/01/2010EP1765850B1 Substituted propane phosphinic acid derivatives
12/01/2010CN1863810B Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and uses as NMDA receptor antagnist
12/01/2010CN1860142B Process for the preparation of a polyolefin
12/01/2010CN101903020A L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same
12/01/2010CN101902914A Azolylmethyloxiranes, use thereof and agents containing the same
12/01/2010CN101899487A Method for in-situ enzymolysis and recovery of cellulose system
12/01/2010CN101899160A Preparation method of oligomerization phosphate polyalcohol
12/01/2010CN101899066A 2-[(diethoxy thiophosphamide) methyl]-4-aryl-5,5-dimethyl-1,3,2-dioxide phospha cyclohexane compound
12/01/2010CN101899065A Glyphosate triammonium and preparation method and application thereof
12/01/2010CN101899064A Preparation method of dihydric phenol di(dialkyl phenyl organic phosphate)
12/01/2010CN101898978A Eflornithine prodrug and conjugate and using method thereof
12/01/2010CN101898977A GABA (Gamma-Aminobutyric Acid) conjugates and using method thereof
12/01/2010CN101898953A Technological research for producing sodium acetate by comprehensively utilizing chemical waste liquid
12/01/2010CN101289462B Process for preparing acephate from ethenone
12/01/2010CN101153046B Boronation phosphoryl phosphor hydrazide ester, preparing method and application of the same
12/01/2010CN101048165B Process for the preparation of ibandronate
11/2010
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/30/2010CA2399017C Novel phosphorus compounds
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010135398A1 Dopo derivative flame retardants
11/25/2010WO2010135393A1 Dopo-derived flame retardant and epoxy resin composition
11/25/2010WO2010134045A1 Amorphous fosamprenavir calcium
11/25/2010WO2010133851A1 Preparation of labelled compounds
11/25/2010WO2010133608A1 Method for synthesising a rare earth organophosphate and use thereof to prepare a "preformed" catalytic system
11/25/2010WO2010051890A8 Method for producing mono-vinylfunctionalized dialkylphosphinic acid, salts and esters thereof, and the use thereof
11/25/2010WO2009079627A3 Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant e6020
11/25/2010US20100298559 Optically active dinickel complex and method for producing optically active amine using the optically active dinickel complex as catalyst
11/25/2010US20100298506 Method for producing an amino group-containing phosphate compound, and a flame-retardant resin and flame-retardant resin composition
11/25/2010US20100298470 Process for continuously preparing an organophosphorus compound and use thereof
11/25/2010US20100298276 Thyroid receptor ligands
11/25/2010US20100298272 Phosphorus containing heterocyclic compounds, sugar analogues, and compositions having anti-cancer activity containing the same
11/25/2010US20100298271 Compounds for use in the treatment of cancer
11/25/2010US20100298270 Novel Compounds and Methods of Using Them
11/25/2010US20100298269 Prodrugs of cgrp receptor antagonists
11/25/2010US20100298257 Nucleoside phosphoramidates
11/25/2010US20100298256 Antiviral compounds
11/25/2010US20100297768 Nanofibrillar structure and applications including cell and tissue culture
11/25/2010US20100297460 Composition and method for treating wood
11/25/2010US20100297034 Osmolyte-containing preparation for use in case of dry mucous membranes
11/25/2010US20100297020 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
11/25/2010CA2819700A1 N- [(2'r) -2'-deoxy-2'-fluoro-2' -methyl-p-phenyl-5' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
11/25/2010CA2761753A1 Dopo-derived flame retardant and epoxy resin composition
11/25/2010CA2761751A1 Dopo derivative flame retardants
11/24/2010EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
11/24/2010EP2253638A2 Fluoralkylfluorophosphate salts
11/24/2010EP2134732B1 [(4-oxo-4h-chromen-3-yl)-hydroxy methyl]- or [(4-oxo-4h-chromen-3-yl)-methyl]-phosphonic acid derivates
11/24/2010EP1979361B1 Oxonium and sulfonium salts
11/24/2010EP1948670B1 Method of separating acids from chemical reaction mixtures by means of apolar tertiary amines
11/24/2010CN101891768A 9-(diethoxy) phosphonomethyl purine, preparation method and application thereof in antineoplastic aspect
11/24/2010CN101891767A Preparation method of adefovir dipivoxil
11/24/2010CN101891766A Method for preparing beta-methyl carbapenem antibiotic parent nucleus
11/24/2010CN101891765A Method for producing N-(phosphonomethyl) iminodiacetic acid (PMIDA)
11/24/2010CN101891764A Method for preparing N-phosphonomethyliminodiacetic acid
11/24/2010CN101891763A Production method of N-(phosphonomethyl)glycine
11/24/2010CN101891762A Preparation method and application of diethyl phosphinates
11/24/2010CN101891761A Method for catalytically synthesizing triethyl phosphate by phase transfer
11/24/2010CN101891760A Improved process for the preparation of oxidized phospholipids
11/24/2010CN101891752A Prodrug of DCK (deoxycytidine kinase) analogue, preparation method and application thereof
11/24/2010CN101230043B 3-oxide-2-methylamide derivatives as well as preparation method and use thereof
11/23/2010US7838665 Chemoselective ligation
11/23/2010US7838554 dyslipidemia; regulating lipid, lipoprotein, insulin, glucose levels in the blood; 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid; 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol; 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; 2,2,14,14-Tetramethyl-pentadecane-1,6,10,15-tetraol
11/23/2010US7838548 antagonists; oligopeptide of N-(3-indolylacetyl)-L-isoleucine and glycine; IBD, sepsis, periodontal disease, mucositis, acne, cardiovascular disease, COPD, arthritis, cystic fibrosis, infections, ischemia/reperfusion, asthma, stroke, brain injuries, enterocolitis, bed sores, leprosy, atopic dermatitis
11/23/2010US7838299 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging
11/23/2010US7838073 Tantalum amide complexes for depositing tantalum-containing films, and method of making same
11/23/2010US7836898 Reduced tendency of cigarretes to ignite fire-prone substrates by using a permeability reducing substance, a burn rate retardant and a burn rate accelerant that also act as an organoleptic enhancers
11/23/2010CA2529470C Process for controlling crystal structure of risedronate
11/23/2010CA2343798C Catalyst complex with carbene ligand
11/23/2010CA2332808C Compositions of ascorbic acid derivatives for treatment of skin diseases
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/18/2010WO2010131678A1 Method for producing phosphonic acid metal salt fine particles
11/18/2010WO2010130846A2 Palladium phosphine complexes for the telomerization of butadiene
11/18/2010US20100293666 Method of selectively producing male or female sterile plants
11/18/2010US20100292470 Adefovir dipivoxil crystalline monohydrate form
11/18/2010US20100292448 Sleeve Valve